share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph

SEC announcement ·  Apr 16 16:16
Summary by Moomoo AI
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock on April 15, 2024. The transaction involved the acquisition of 16 shares at a price of $750.77 per share. Following this transaction, Alvarez's direct holdings in Eli Lilly and Co amount to 54,029 shares. The total value of the acquired shares at the transaction price is approximately $12,012.32. This transaction reflects a direct investment in the company and indicates Alvarez's continued stake in Eli Lilly's performance.
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock on April 15, 2024. The transaction involved the acquisition of 16 shares at a price of $750.77 per share. Following this transaction, Alvarez's direct holdings in Eli Lilly and Co amount to 54,029 shares. The total value of the acquired shares at the transaction price is approximately $12,012.32. This transaction reflects a direct investment in the company and indicates Alvarez's continued stake in Eli Lilly's performance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more